Duun-Henriksen, A.K. et al. 2022. Prescription rates for drugs used in treatment of benign prostatic hyperplasia and erectile dysfunction before and after prostate cancer diagnosis. Acta Oncologica. 61, 8 (Aug. 2022), 931–938. DOI:https://doi.org/10.1080/0284186X.2022.2082886.